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EXTRAORDINARY CASE REPORT

A Rare Case of Primary Cutaneous Signet-Ring Cell
Melanoma With Discrepant Findings on Gene Expression
Profiling and Chromosomal Microarray Analysis
Wyatt Boothby-Shoemaker, BA,* Michael Kwa, MD,† Laurie Kohen, MD,† Brandon Shaw, PhD,‡
and Ben J. Friedman, MD†‡

Abstract: Melanoma with signet ring cell features is an exceptionally
rare variant of primary cutaneous and metastatic melanoma. The
molecular mechanisms underlying this unusual cytologic phenotype in
malignant melanocytes are largely unknown. In this report, we aim to add
to the literature by describing the histomorphological, immunophenotypic,
gene expression, and cytogenetic ﬁndings in 1 recently encountered case.
Key Words: signet ring cell melanoma, gene expression proﬁling,
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(Am J Dermatopathol 2022;00:1–4)

INTRODUCTION
Melanoma with signet-ring cell features is an exceptionally
rare, previously described histomorphologic variant of primary

cutaneous and metastatic melanoma.1–3 The molecular mechanisms underlying this unusual cytologic phenotype in malignant
melanocytes is largely unknown. Because of the rarity of this
phenomenon, there exists a signiﬁcant potential for misdiagnosis
by the unfamiliar pathologist. We recently encountered a melanocytic neoplasm in consultation that was consistent with signetring cell melanoma. Moreover, this lesion was initially misdiagnosed as a combined nevus in part because of a false-negative
result obtained on a commercially available gene expression
assay. In this report, we aim to add to the literature by describing
the histomorphologic, immunophenotypic, and cytogenetic
abnormalities of this unique tumor in detail. To our knowledge,
this is the ﬁrst detailed case study of this rare melanoma subtype
that includes ﬁndings on both array comparative genomic hybridization (aCGH) and gene expression proﬁling (GEP).

FIGURE 1. Commercially available gene expression assay report.
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REPORT OF A CASE
A 43-year-old Caucasian man with paternal history of
melanoma presented for a second opinion regarding a
growing pigmented lesion on his back. A shave biopsy from
the lesion had previously been interpreted as a “combined
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FIGURE 2. Histopathology. Scanning magnification demonstrating an asymmetric compound melanocytic proliferation
(20·, original magnification).

compound nevus with features of epithelioid blue nevus.”
This diagnosis was notably rendered in the context of a
“benign” score obtained on a commercially available, clinically validated 23-gene expression assay (Fig. 1).4,5
At scanning magniﬁcation, sections demonstrated a
broad and asymmetric compound proliferation of melanocytes (Fig. 2). One half of the lesion consisted of a predominantly junctional component with largely nested melanocytes
seen at the tips and sides of the rete pegs with bridging and
papillary dermal ﬁbroplasia. The other half contained a junctional component with similar qualities, in addition to a large
dermal proliferation of melanocytes in variably sized expansile nests. Asymmetry was apparent and seen in both horizontal and vertical directions, and there was no conspicuous
maturation evident (Fig. 3). On higher power, most melanocytes contained peculiar cytoplasmic vacuolization with
eccentrically compressed and indented nuclei reminiscent of
signet rings and lipoblasts, an uncommon ﬁnding in melanocytic nevi (Fig. 4). Nuclear pleomorphism was notably mildto-moderate throughout much of the lesion.
Features worrisome for melanoma included the apparent asymmetry, uneven cytoplasmic melanization, the presence of large expansile nests in the dermis, lack of maturation,
elevated Ki67 index (10%–15%), and disproportionate
HMB45 reactivity in the deeper portions of the lesion
(Fig. 5). Given the discrepant “benign” gene expression score,
peculiar cytology, and deceptively low-grade nuclear pleomorphism, additional analysis via chromosomal microarray
(via previously described methods6) was pursued. Multiple
deleterious segmental gains and losses were detected, which
was more indicative of a malignant phenotype and consistent
with our impression of a malignant lesion based on the overall
histomorphologic and immunophenotypic features.7,8
Speciﬁcally, there were copy number gains in the 5p, 16p,
17p, and 20q regions; copy number losses in the 5p, 5q, 17p,
and 20p regions; copy neutral loss of heterozygosity (LOH)
were found in regions 5p, 5q, 16p, and 20p (Fig. 6).

FIGURE 3. Histopathology. Medium power view demonstrating variably sized nests of melanocytes with patchy melanization and no conspicuous maturation in the dermis (100·,
original magnification).

precipitated by the accumulation of substances within the
cytoplasm that then compress the nucleus against the plasma
membrane. Signet ring cells are perhaps most commonly
associated with gastrointestinal adenocarcinomas, in which
the cytoplasm ﬁlls with mucin. Although generally uncommon in cutaneous neoplasms, this phenomenon has rarely
been reported in melanoma, squamous cell carcinoma, hidradenoma, cylindroma, basal cell carcinomas, mycosis fungoides, and liposarcoma. Bastian et al1 proposed that the
appearance of signet ring cells in a selection of primary and
secondary cutaneous tumors resulted from the accumulation
of a variety of intracytoplasmic material, including mucin,
glycogen, vimentin, and keratin. Kocovski et al hypothesized
that intracytoplasmic inclusions in signet ring cell melanoma
were likely caused by vimentin based on immunohistochemical staining of 23 prior cases and ﬁndings of vimentin ﬁlaments on electron microscopy.11 Whether these changes are
analogous to and/or on the spectrum of the balloon cell and
sebocyte-like cytology seen in other melanocytic lesions
remains to be determined.12

DISCUSSION
Melanoma has been known to demonstrate unusual
morphologies including rhabdoid, nevoid, balloon cell,
sebocyte-like, desmoplastic, and dedifferentiated forms.9
These morphologies may on occasions pose diagnostic difﬁculty in distinguishing between benign nevi and other nonmelanocytic malignant tumors. Signet ring cytology in melanoma is an exceedingly uncommon ﬁnding,1,10 and may be

FIGURE 4. Histopathology. High-power view demonstrating
numerous vacuolated melanocytes resembling signet ringcells and lipoblasts (200x, original magnification).
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Signet-Ring Cell Melanoma

FIGURE 5. A, HMB45 immunohistochemical stain demonstrating
uneven labeling with no gradient
(100·, original magnification). B,
MIB immunohistochemical stain
demonstrating an elevated proliferation index (200·, original
magnification).

To our knowledge, this is the ﬁrst reported case of
signet ring cell melanoma evaluated via aCGH. LOH in our
case was identiﬁed on 5p, 5q, 16p, and 20p. These regions did
not overlap with the 7 most frequent chromosomal arms
demonstrating LOH in melanoma based on one study of 76
melanoma lines. This could perhaps implicate a unique
cytogenetic signature for melanoma with signet-ring features,
although larger studies focusing on this speciﬁc entity would
be needed for conﬁrmation.13 Interestingly gains in 20q were

among the most frequent cytogenomic ﬁndings in melanoma
in that study, which provides further support for the diagnosis
in this case.
Commercially available GEP assays are increasingly
being used by dermatopathologists when faced with difﬁcult
melanocytic lesions to help support or refute a histomorphologic diagnosis of melanoma.14 These often use quantitative
reverse transcription polymerase chain reactions to measure
the expression of multiple genes and assign a score to a lesion

FIGURE 6. Chromosomal SNP array (upper panel: copy number data, lower panel: allelic ratio plot).
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based on a proprietary, clinically validated algorithm. Based
on the score, lesions are classiﬁed as “benign,” “indeterminate,” or “malignant.” The test reports a sensitivity of 90%–
94% and speciﬁcity of 91%–96% in establishing a diagnosis
of malignant melanoma based on prior validation studies.4 As
demonstrated in this case, caution must be exercised when
interpreting the results of GEP assays, especially in the setting
of unusual histomorphologic variants that may have not been
adequately represented in the initial validation assays.
Moreover, validation of these tests has typically been based
on consensus agreement with 2 or 3 expert dermatopathologists rather than clinical outcome. Studies to date that have
compared the results of FISH, GEP, aCGH on the same cases,
have generally found that aCGH tends to agree more with
expert consensus diagnosis based on histopathology alone.15
Given these limitations, adjunctive GEP for the diagnosis of
melanoma is still not fully endorsed by the American Society
of Dermatopathology Acceptable Use Criteria, as more longterm outcome data are needed.16
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